Variant report
Variant | nsv611447 |
---|---|
Chromosome Location | chr8:63867493-63883593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7835051 | chr8:63867493-63867494 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs184849698 | chr8:63867528-63867529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188496290 | chr8:63867529-63867530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181687491 | chr8:63867555-63867556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533900241 | chr8:63867578-63867579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79103675 | chr8:63867581-63867582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112587625 | chr8:63867591-63867592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200376179 | chr8:63867606-63867607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537983478 | chr8:63867652-63867653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140848130 | chr8:63867659-63867660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577862931 | chr8:63867684-63867685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12676761 | chr8:63867814-63867815 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs185820630 | chr8:63867841-63867842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs28680269 | chr8:63867847-63867848 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs542231486 | chr8:63867973-63867974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560893606 | chr8:63867975-63867976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4570149 | chr8:63867979-63867980 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs543580814 | chr8:63867987-63867988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565070478 | chr8:63868018-63868019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532160186 | chr8:63868040-63868041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547578263 | chr8:63868044-63868045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559349402 | chr8:63868093-63868094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541512320 | chr8:63868094-63868095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575652678 | chr8:63868095-63868096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531800280 | chr8:63868103-63868104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs57138912 | chr8:63868146-63868147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs16929941 | chr8:63868149-63868150 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs188771808 | chr8:63868169-63868170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148969256 | chr8:63868180-63868181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17277118 | chr8:63868216-63868217 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs571725712 | chr8:63868239-63868240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367785543 | chr8:63868240-63868241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554368452 | chr8:63868271-63868272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572628454 | chr8:63868284-63868285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74600226 | chr8:63868290-63868291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182132585 | chr8:63868323-63868324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554593721 | chr8:63868337-63868338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187258227 | chr8:63868350-63868351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138362226 | chr8:63868358-63868359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190838258 | chr8:63868390-63868391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143907094 | chr8:63868392-63868393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147280695 | chr8:63868395-63868396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12543961 | chr8:63868434-63868435 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs542224323 | chr8:63868475-63868476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139023155 | chr8:63868525-63868526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549915301 | chr8:63868527-63868528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541769368 | chr8:63868605-63868606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565061143 | chr8:63868606-63868607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531561870 | chr8:63868609-63868610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549782146 | chr8:63868692-63868693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63859600-63877800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr8:63866600-63867800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr8:63867800-63868000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr8:63867800-63868600 | Enhancers | Fetal Brain Female | brain |
5 | chr8:63868200-63869200 | Enhancers | Fetal Brain Male | brain |
6 | chr8:63868600-63895800 | Weak transcription | Fetal Brain Female | brain |
7 | chr8:63870800-63871200 | Enhancers | Placenta | Placenta |
8 | chr8:63871200-63871600 | Weak transcription | Placenta | Placenta |
9 | chr8:63871600-63871800 | Enhancers | Placenta | Placenta |
10 | chr8:63871800-63875400 | Weak transcription | Placenta | Placenta |
11 | chr8:63875400-63876600 | Enhancers | Placenta | Placenta |
12 | chr8:63877400-63878000 | Enhancers | Brain Germinal Matrix | brain |
13 | chr8:63877800-63880200 | Strong transcription | Cortex derived primary cultured neurospheres | brain |
14 | chr8:63878000-63892000 | Weak transcription | Brain Germinal Matrix | brain |
15 | chr8:63880200-63888000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |